Premenstrual Relief

Natural health product licensed in Canada

Other names: Premenstrual Care
Licence holder: Red Maple Bio Inc.
NPN or DIN-HM: 80097422
Status: Active licence
Licence date: 5 March 2020
Revision date: 10 February 2025
Form: Capsule
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

Dose déclarée au-delà d'une limite
Vitamine B6: up to 20 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
À vérifier
Vitamine B6: up to 20 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Dioscorea villosa Source : Plante entière Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg	50 mg	Not calculated
Actaea racemosa Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 mg	50 mg	Not calculated
Pinus pinaster Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg	50 mg	Not calculated
Vitex agnus-castus Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg	50 mg	Not calculated
Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 mg	50 mg	Not calculated
Vitamine D Source : Cholécalciférol	6.25 Microgrammes	Not calculated
Vitamine B6 Source : Pyridoxamine	10 mg	20,000 µg
Vitamine B12 Source : Cyanocobalamine	1.5 Microgrammes	Not calculated
Magnésium Source : Oxyde de magnésium	29 mg	58,000 µg
Rubus idaeus Source : Feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg	50 mg	Not calculated
Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg	50 mg	Not calculated
Passiflora incarnata Source : Sommité Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg	50 mg	Not calculated

Non-medicinal ingredients

Cellulose microcristalline, Stéarate de magnésium, Gélatine, Dioxyde de silicium

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 19 years	1 Capsule	2 Tous les jours

Uses authorised in Canada

Black Cohosh Used in Herbal Medicine to help relieve the pain associated with menstruation as well as premenstrual symptoms. Chasteberry Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities and relieve premenstrual symptoms. Ginger Help(s) prevent nausea and vomiting associated with motion sickness, and/or seasickness. Ginger Traditionally used in Herbal Medicine to help relieve digestive upset including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia, and flatulent colic (carminative) Ginger Traditionally used in Herbal Medicine as an expectorant and cough suppressant (antitussive) to help relieve bronchitis as well as coughs and colds. Passionflower (Traditionally) used in Herbal Medicine to help relieve restlessness and/or nervousness (calmative) .

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.